Biotech

Showing of Insights Posts
Health care Biotech Innovation Economic cycle Equity Global Industry Research Article Outlook
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Health care outlook for 2023

Looking ahead to 2023, members of our health care team see meaningful innovation, supportive valuations, and a benign political and regulatory backdrop across biopharma, medical tech, and health care services sectors.

Continue reading

Multiple authors

event
Article
2023-12-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
Equity Biotech Macro and market Fiscal policy USA Quick Take
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
Drug pricing reform: A bitter pill for biopharma?
Global Industry Analyst Wen Shi considers the implications of drug price reform for biotech companies — modest in the near term, but likely negative longer term.
Continue reading

By

Wen Shi, PhD, CFA

event
Quick Take
2023-01-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
Future Themes Innovation Sustainability Climate Macro and market Fintech Biotech
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
Tomorrow’s world today
For over 40 years, at each new business cycle, Wellington investors have been presented with a challenge: Look past current headlines to find structural trendlines that will shape markets, society and the economy in the next five to 10 years. Our goal is to extend our horizons, gather a range of diverse ideas, ignite debate and collaboration and identify potential investment opportunities ahead of the market.
Continue reading
event
2023-05-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
3 LOAD {count} MORE

URL References

Related Insights

 © Copyright 2023 Wellington Management Europe GmbH. All rights reserved.
WELLINGTON MANAGEMENT FUNDS ® is a registered service mark of Wellington Group Holdings LLP.
Wellington Management Europe GmbH. Registered office: Bockenheimer Landstraße 43-47, 60325 Frankfurt am Main, Germany. T: +49-69-677761-500. VAT-number DE 326304943 (Umsatzsteuer-Identifikationsnummer) Commercial Register of the local court Frankfurt am Main (Handelsregister des Amtsgericht Frankfurt am Main), HRB 115460 .

Wellington Management Europe GmbH, is authorised and regulated by the German Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht)
For professional investors and intermediaries only. This content is not suitable for a retail audience.

View More

we’d love your feedback!

Help us improve our website. For every short survey taken, we give 2 to the Wellington Management UK Foundation to support educational charities helping economically disadvantaged children in EMEA.